Granted Patent
B2
US 10,927,082 · App. 16/886,642 · Granted Feb 23, 2021
Farnesoid X receptor agonists and uses thereof
Inventors:
Nicholas D. Smith (San Diego, CA); Stephen P. Govek (San Diego, CA); Johnny Y. Nagasawa (San Diego, CA)
Assignee:
METACRINE, INC.
C07D231/12A61K9/0014A61K9/0029A61K9/0053A61K9/06A61K9/2054A61K9/4866A61P1/00A61P1/16C07D401/04C07D401/14C07D403/12C07D405/12C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Claims (4)
1. A compound that has the following structure:
or a pharmaceutically acceptable salt, or solvate thereof.
2. A pharmaceutical composition comprising a compound that has the following structure:
or a pharmaceutically acceptable salt, or solvate thereof; and at least one pharmaceutically acceptable excipient.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 21, 2025
From: ORGANOVO, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 070892/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 18, 2023
From: METACRINE, INC.
To: ORGANOVO, INC.
Reel/Frame 063354/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 9, 2020
From: SMITH, NICHOLAS D.; GOVEK, STEVEN P.; NAGASAWA, JOHNNY Y.
To: METACRINE, INC.
Reel/Frame 052883/0227 →
Continuity (3)
Continuation
16494264
Provisional Application
62471517
· Mar 15, 2017